Matteo Puntoni

7.3k total citations · 2 hit papers
139 papers, 4.8k citations indexed

About

Matteo Puntoni is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Matteo Puntoni has authored 139 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 28 papers in Cancer Research and 26 papers in Molecular Biology. Recurrent topics in Matteo Puntoni's work include Metabolism, Diabetes, and Cancer (16 papers), Estrogen and related hormone effects (16 papers) and Cancer Risks and Factors (15 papers). Matteo Puntoni is often cited by papers focused on Metabolism, Diabetes, and Cancer (16 papers), Estrogen and related hormone effects (16 papers) and Cancer Risks and Factors (15 papers). Matteo Puntoni collaborates with scholars based in Italy, United Kingdom and Switzerland. Matteo Puntoni's co-authors include Andrea DeCensi, Alessandra Gennari, Sara Gandini, Bernardo Bonanni, Massimiliano Cazzaniga, Pamela J. Goodwin, Paolo Bruzzi, Barbara K. Dunn, Brandy M. Heckman‐Stoddard and Éva Szabó and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Matteo Puntoni

133 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

2010 713 citations Andrea DeCensi, Matteo Puntoni et al. Cancer Prevention Research profile →
Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis

2022 111 citations Giuseppe Maglietta, Francesca Diodati et al. Journal of Clinical Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matteo Puntoni Italy	33	1.8k	1.7k	1.2k	731	668	139	4.8k
Agnes Jager Netherlands	46	2.5k 1.4×	1.4k 0.9×	1.7k 1.4×	658 0.9×	1.1k 1.6×	227	7.0k
Gad Rennert Israel	48	2.7k 1.5×	1.9k 1.1×	1.9k 1.6×	1.0k 1.4×	1.5k 2.3×	224	8.1k
Irene Helenowski United States	39	1.7k 1.0×	898 0.5×	563 0.5×	877 1.2×	335 0.5×	232	5.7k
Joshua A. Bell United Kingdom	35	1.5k 0.8×	1.1k 0.7×	937 0.8×	408 0.6×	549 0.8×	90	4.2k
Robert K. Hills United Kingdom	57	2.2k 1.2×	5.4k 3.2×	997 0.8×	635 0.9×	375 0.6×	246	14.8k
Greta R. Bunin United States	41	1.0k 0.6×	1.2k 0.7×	582 0.5×	656 0.9×	517 0.8×	93	5.8k
James L. Wade United States	45	4.3k 2.4×	1.3k 0.8×	1.3k 1.1×	796 1.1×	1.4k 2.1×	153	7.6k
Søren Friis Denmark	44	1.6k 0.9×	1.1k 0.6×	1.5k 1.2×	1.9k 2.6×	633 0.9×	204	6.6k
Stig E. Bojesen Denmark	50	1.8k 1.0×	2.4k 1.4×	1.7k 1.4×	874 1.2×	863 1.3×	172	8.3k
Johannes M.G. Bonfrèr Netherlands	33	1.4k 0.8×	1.1k 0.7×	463 0.4×	467 0.6×	299 0.4×	67	4.1k

Countries citing papers authored by Matteo Puntoni

Since Specialization

Citations

This map shows the geographic impact of Matteo Puntoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Puntoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Puntoni more than expected).

Fields of papers citing papers by Matteo Puntoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Puntoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Puntoni. The network helps show where Matteo Puntoni may publish in the future.

Co-authorship network of co-authors of Matteo Puntoni

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Puntoni. A scholar is included among the top collaborators of Matteo Puntoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Puntoni. Matteo Puntoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carbone, Alessio, Martino Oliva, Matteo Puntoni, et al.. (2025). Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer. JNCI Journal of the National Cancer Institute.

Carbone, Annalucia, Matteo Puntoni, Leone Giordano, et al.. (2025). 350P Long-term gynaecological safety and benign breast disease on low-dose tamoxifen: 10-year results from the TAM-01 phase III trial. Annals of Oncology. 36. S330–S330. 1 indexed citations

Maglietta, Giuseppe, Matteo Puntoni, Caterina Caminiti, et al.. (2024). Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study interrupted time-series analysis. Frontiers in Public Health. 12. 1393677–1393677. 2 indexed citations

Esposito, Susanna, et al.. (2023). True prevalence of long COVID in children: a narrative review. Frontiers in Microbiology. 14. 1225952–1225952. 3 indexed citations

Puntoni, Matteo, Susanna Esposito, Laura Patrizi, et al.. (2023). Impact of Age and Sex Interaction on Post-Acute Sequelae of COVID-19: An Italian Cohort Study on Adults and Children. Journal of Clinical Medicine. 12(8). 2924–2924. 3 indexed citations

Musacchio, Clarissa, Carlo Custodero, Monica Razzano, et al.. (2022). Association between multidimensional prognostic index (MPI) and pre-operative delirium in older patients with hip fracture. Scientific Reports. 12(1). 16920–16920. 5 indexed citations

Maglietta, Giuseppe, Francesca Diodati, Matteo Puntoni, et al.. (2022). Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 11(6). 1541–1541. 111 indexed citations breakdown →

Caminiti, Caterina, Giuseppe Maglietta, Francesca Diodati, et al.. (2022). The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis. Cancers. 14(21). 5470–5470. 25 indexed citations

Giardino, Stefano, Arnoldo Piccardo, Massimo Conte, et al.. (2020). ¹³¹I‐Meta‐iodobenzylguanidine followed by busulfan and melphalan and autologous stem cell rescue in high‐risk neuroblastoma. Pediatric Blood & Cancer. 68(2). e28775–e28775. 5 indexed citations

10.

Brunasso, Alexandra Maria Giovanna, Matteo Puntoni, & Cesare Massone. (2019). Palmoplantar Pustulosis and Allergies: A Systematic Review. Dermatology Practical & Conceptual. 9(2). 105–110. 12 indexed citations

11.

Piccardo, Arnoldo, Pierpaolo Trimboli, Matteo Puntoni, et al.. (2019). Role of ¹⁸ F-Choline Positron Emission Tomography/Computed Tomography to Detect Structural Relapse in High-Risk Differentiated Thyroid Cancer Patients. Thyroid. 29(4). 549–556. 11 indexed citations

12.

Garbarino, Sergio, Ottavia Guglielmi, Matteo Puntoni, Nicola Luigi Bragazzi, & Nicola Magnavita. (2019). Sleep Quality among Police Officers: Implications and Insights from a Systematic Review and Meta-Analysis of the Literature. International Journal of Environmental Research and Public Health. 16(5). 885–885. 71 indexed citations

13.

Clavarezza, Matteo, Matteo Puntoni, Alessandra Gennari, et al.. (2016). Dual Block with Lapatinib and Trastuzumab Versus Single-Agent Trastuzumab Combined with Chemotherapy as Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Meta-analysis of Randomized Trials. Clinical Cancer Research. 22(18). 4594–4603. 27 indexed citations

14.

Cella, Alberto, et al.. (2016). Frailty is associated with socioeconomic and lifestyle factors in community-dwelling older subjects. Aging Clinical and Experimental Research. 29(4). 721–728. 55 indexed citations

15.

DeCensi, Andrea, Matteo Puntoni, Aliana Guerrieri‐Gonzaga, et al.. (2015). Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial. Cancer Prevention Research. 8(10). 888–894. 27 indexed citations

16.

Gandini, Sara, Matteo Puntoni, Brandy M. Heckman‐Stoddard, et al.. (2014). Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders. Cancer Prevention Research. 7(9). 867–885. 340 indexed citations

17.

Bonanni, Bernardo, Matteo Puntoni, Massimiliano Cazzaniga, et al.. (2012). Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial. Journal of Clinical Oncology. 30(21). 2593–2600. 195 indexed citations

18.

Puntoni, Matteo, Alessandra Argusti, C. Crosta, et al.. (2012). A Randomized, Placebo-Controlled, Preoperative Trial of Allopurinol in Subjects with Colorectal Adenoma. Cancer Prevention Research. 6(2). 74–81. 14 indexed citations

19.

DeCensi, Andrea, Matteo Puntoni, Pamela J. Goodwin, et al.. (2010). Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis. Cancer Prevention Research. 3(11). 1451–1461. 713 indexed citations breakdown →

20.

Gennari, Alessandra, Maria Pia Sormani, P. Pronzato, et al.. (2007). HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials. JNCI Journal of the National Cancer Institute. 100(1). 14–20. 258 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact